Kennebec Savings Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Kennebec Savings Bank's MRNA Position: Q2 2026 in Review
Kennebec Savings Bank held its Moderna (MRNA) position steady in Q2 2026 at 121 shares worth $8.47K. The position accounts for 0.01% of the portfolio, ranked #242.
Kennebec Savings Bank first reported a position in MRNA in Q3 2024 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Kennebec Savings Bank held 121 shares of Moderna worth $8.47K as of Q2 2026.
- Kennebec Savings Bank left its Moderna share count unchanged in Q2 2026.
- Moderna made up 0.01% of Kennebec Savings Bank's portfolio in Q2 2026, its #242 holding.
- Kennebec Savings Bank first reported a position in Moderna in Q3 2024 and has held it in 8 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.